Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, withdrew its plans for an initial public offering on Thursday. It had originally set terms in March 2015 to raise $75 million by offering 5.0...read more
Insulet, a medical device maker that has developed a highly integrated insulin infusion system for diabetes patients, priced 7.7 million shares (1 million shares more than expected) at $15, the mid-point of its proposed $14-$16 range. Merrill Lynch and JP...read more
Insulet, the developer of a discreet and easy-to-use insulin infusion system for diabetics, announced the terms of its IPO Wednesday. The company plans to offer 6.7 million shares at $14.00 to $16.00 per share. JPMorgan and Merrill Lynch are bookrunning the...read more
Insulet, a medical device company that develops, manufactures, and markets an innovative, discreet and easy-to-use insulin infusion system, filed for an IPO Wednesday. J.P. Morgan and Merrill Lynch are the joint lead managers on the deal. Terms and timing are ...read more
Insulin pump is bumped: Valeritas officially withdraws $75 million IPO
Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, withdrew its plans for an initial public offering on Thursday. It had originally set terms in March 2015 to raise $75 million by offering 5.0...read more
Medical device maker Insulet prices more shares than expected at $15
Insulet, a medical device maker that has developed a highly integrated insulin infusion system for diabetes patients, priced 7.7 million shares (1 million shares more than expected) at $15, the mid-point of its proposed $14-$16 range. Merrill Lynch and JP...read more
Insulin infusion system developer Insulet announces terms
Insulet, the developer of a discreet and easy-to-use insulin infusion system for diabetics, announced the terms of its IPO Wednesday. The company plans to offer 6.7 million shares at $14.00 to $16.00 per share. JPMorgan and Merrill Lynch are bookrunning the...read more
Insulin infusion system developer Insulet files for IPO
Insulet, a medical device company that develops, manufactures, and markets an innovative, discreet and easy-to-use insulin infusion system, filed for an IPO Wednesday. J.P. Morgan and Merrill Lynch are the joint lead managers on the deal. Terms and timing are ...read more